Mictonorm Uno (Propiverine Hydrochloride)

Propiverine hydrochloride works by selectively blocking muscarinic (M2 and M3) receptors in the bladder detrusor muscle. This antagonism reduces involuntary muscle contractions, increases bladder capacity, and consequently lessens urgency, frequency and episodes of urge incontinence.

The appropriate dose of Mictonorm Uno is determined by the prescribing healthcare professional based on the individual’s condition, response, and tolerability. Dosage may be adjusted during treatment, and patients should follow the prescriber’s instructions without self‑adjusting the regimen.

The safety of propiverine hydrochloride in pregnancy and lactation has not been established. It is generally advised to avoid use unless the potential benefit justifies the potential risk, and the decision should be made in consultation with a qualified healthcare provider.

To order Mictonorm Uno, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mictonorm Uno belongs to the same antimuscarinic class as drugs like oxybutynin and tolterodine. While efficacy in reducing urgency and frequency is comparable, differences may exist in side‑effect profiles, dosing frequency and drug‑interaction potential, allowing clinicians to tailor therapy to individual patient needs.

Mictonorm Uno should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight and heat sources. Do not use the product after the expiry date printed on the label.

Mictonorm Uno is taken orally as a tablet. The tablet should be swallowed whole with a glass of water, preferably at the same time each day. Patients should not crush, chew, or split the tablet unless specifically instructed by their prescriber.

Serious risks include urinary retention, which can lead to bladder overflow; severe allergic reactions such as anaphylaxis; angle‑closure glaucoma, which may cause sudden vision loss; and hepatic dysfunction. Patients should seek immediate medical attention if they experience any of these events.

Mictonorm Uno should be avoided in patients with known urinary retention, narrow‑angle glaucoma, severe hepatic impairment, or those taking other strong anticholinergic medications that could increase anticholinergic burden. Contra‑indications are determined by the prescriber based on individual medical history.